Collegium Pharmaceutical, Inc. (COLL) Social Stream
COLLEGIUM PHARMACEUTICAL INC (COLL) Price Targets From Analysts
Use the tables below to see what analysts covering COLLEGIUM PHARMACEUTICAL INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $36 | $8 | $24.857 | $32.28 | -23% |
| 2021-11-28 | 8 | $36 | $8 | $25.142 | $32.28 | -22.11% |
| 2022-01-11 | 6 | $36 | $8 | $25.142 | $32.28 | -22.11% |
| 2022-01-21 | 6 | $36 | $8 | $25 | $32.28 | -22.55% |
| 2022-02-15 | 7 | $36 | $8 | $25.5 | $32.28 | -21% |
| 2022-02-25 | 7 | $42 | $8 | $26.5 | $32.28 | -17.91% |
| 2022-04-06 | 7 | $42 | $8 | $27 | $32.28 | -16.36% |
| 2022-04-28 | 7 | $40 | $8 | $26.666 | $32.28 | -17.39% |
| 2022-05-10 | 7 | $37 | $8 | $26.166 | $32.28 | -18.94% |
| 2022-07-18 | 8 | $37 | $8 | $27.714 | $32.28 | -14.14% |
| 2022-08-05 | 6 | $37 | $8 | $27.333 | $32.28 | -15.33% |
| 2022-11-30 | 6 | $35 | $8 | $25.8 | $32.28 | -20.07% |
| 2023-01-06 | 6 | $40 | $8 | $30.2 | $32.28 | -6.44% |
| 2023-01-09 | 6 | $35 | $8 | $27.4 | $32.28 | -15.12% |
| 2023-02-08 | 6 | $35 | $26 | $32.25 | $32.28 | -0.09% |
| 2023-02-12 | 6 | $36 | $26 | $32.5 | $32.28 | 0.68% |
| 2023-02-16 | 6 | $40 | $33 | $36 | $32.28 | 11.52% |
| 2023-04-19 | 6 | $40 | $33 | $36.25 | $32.28 | 12.3% |
| 2023-04-25 | 7 | $40 | $33 | $35.75 | $32.28 | 10.75% |
| 2023-05-09 | 6 | $40 | $30 | $35 | $32.28 | 8.43% |
| 2023-07-04 | 7 | $40 | $30 | $34.6 | $32.28 | 7.19% |
| 2023-07-25 | 6 | $35 | $30 | $33.25 | $32.28 | 3% |
| 2023-08-08 | 6 | $37 | $30 | $33.75 | $32.28 | 4.55% |
| 2023-08-25 | 6 | $37 | $30 | $34 | $32.28 | 5.33% |
| 2023-11-10 | 6 | $37 | $30 | $33.5 | $32.28 | 3.78% |
The Trend in the Analyst Price Target
Over the past 31 months, COLL's average price target has gone up $3.93.
Over the past 39 weeks, COLL's average upside potential has been 47.31%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-08 | 7 | 40 | 30 | 34.60 | 23.42 | 47.74% |
| 2023-05-09 | 7 | 40 | 30 | 35.00 | 23.53 | 48.75% |
| 2023-07-04 | 7 | 35 | 30 | 33.25 | 21.43 | 55.16% |
| 2023-07-04 | 6 | 40 | 30 | 34.60 | 21.43 | 61.46% |
| 2023-11-10 | 6 | 37 | 30 | 33.50 | 24.48 | 36.85% |
COLL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 4 | 1 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
COLL's average broker recommendation rating improved by 0 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, COLLEGIUM PHARMACEUTICAL INC's variance in analysts' estimates is lower than -1776.46% of them.
- COLLEGIUM PHARMACEUTICAL INC's upside potential (average analyst target price relative to current price) is higher than 328.09% of stocks in the small market cap category.
- COLL has a greater number of analysts covering the stock than 2291.45% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, COLLEGIUM PHARMACEUTICAL INC's average analyst price target is greater than 2167.24% of them.
In the Pharmaceutical Products industry, AKBA, EGRX, and CPRX are the three stocks most similar to COLLEGIUM PHARMACEUTICAL INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for COLL? Use POWR Ratings for clearer insight into price direction.